Why the study?
Perirenal adipose tissue has recently been recognized as an important contributor to cardiovascular and kidney homeostasis, but its roles across various pathologies warranted a summary of current knowledge.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Perirenal adipose tissue may inform cardiometabolic risk assessment; leaves open targeted interventions pending prospective validation.
The perirenal adipose tissue (PRAT), a component of visceral adipose tissue, has been recently recognized as an important factor that contributes to the maintenance of the cardiovascular system and kidney homeostasis. PRAT is a complex microenvironment consisting of a mixture of white adipocytes and dormant and active brown adipocytes, associated with predipocytes, sympathetic nerve endings, vascular structures, and different types of inflammatory cells. In this review, we summarize the current knowledge about PRAT and discuss its role as a major contributing factor in the pathogenesis of hypertension, obesity, chronic renal diseases, and involvement in tumor progression. The new perspectives of PRAT as an endocrine organ and recent knowledge regarding the possible activation of dormant brown adipocytes are nowadays considered as new areas of research in obesity, in close correlation with renal and cardiovascular pathology. Supplementary PRAT complex intervention in tumor progression may reveal new pathways involved in carcinogenesis and, implicitly, may identify additional targets for tailored cancer therapy.
No takes yet. Share an insight, caveat, or question.
Grigoraş et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: